<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">34601388</PMID><DateCompleted><Year>2021</Year><Month>10</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2211-0356</ISSN><JournalIssue CitedMedium="Internet"><Volume>55</Volume><PubDate><Year>2021</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Multiple sclerosis and related disorders</Title><ISOAbbreviation>Mult Scler Relat Disord</ISOAbbreviation></Journal><ArticleTitle>Long COVID or post COVID-19 syndrome.</ArticleTitle><Pagination><StartPage>103268</StartPage><MedlinePgn>103268</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.msard.2021.103268</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2211-0348(21)00535-6</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lechner-Scott</LastName><ForeName>J</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Levy</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Hawkes</LastName><ForeName>C</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Yeh</LastName><ForeName>A</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Giovannoni</LastName><ForeName>G</ForeName><Initials>G</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Mult Scler Relat Disord</MedlineTA><NlmUniqueID>101580247</NlmUniqueID><ISSNLinking>2211-0348</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005221" MajorTopicYN="N">Fatigue</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cognitive impairment</Keyword><Keyword MajorTopicYN="N">Fatigue</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post COVID-19</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>10</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>10</Month><Day>3</Day><Hour>20</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34601388</ArticleId><ArticleId IdType="pmc">PMC8447548</ArticleId><ArticleId IdType="doi">10.1016/j.msard.2021.103268</ArticleId><ArticleId IdType="pii">S2211-0348(21)00535-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ameres M., Brandstetter S., Toncheva A.A., et al. Association of neuronal injury blood marker neurofilament light chain with mild-to-moderate COVID-19. J. Neurol. 2020;267:3476&#x2013;3478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7345451</ArticleId><ArticleId IdType="pubmed">32647900</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell C.J., Howard C.R., Murphy FA., Burrell C.J., Howard C.R., Murphy F.A. Fenner and White's Medical Virology. 5th Ed. Academic Press; London: 2017. Chapter 39-Viral syndromes; pp. 537&#x2013;556.</Citation></Reference><Reference><Citation>Bell M.L., Catalfamo C.J., Farland L.V., et al. Post-acute sequelae of COVID-19 in a non-hospitalized cohort: results from the Arizona CoVHORT. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8336814</ArticleId><ArticleId IdType="pubmed">34347785</ArticleId></ArticleIdList></Reference><Reference><Citation>Balestrieri E., Minutolo A., Petrone V., et al. Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients. EBioMedicine. 2021;66 doi: 10.1016/j.ebiom.2021.103341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2021.103341</ArticleId><ArticleId IdType="pmc">PMC8082064</ArticleId><ArticleId IdType="pubmed">33867312</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324:603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V., Flanders S.A., O'Malley M., Malani A.N., Prescott H.C. Sixty-day outcomes among patients hospitalized with COVID-19. Ann. Intern. Med. 2021;174:576&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID L S. Unraveling the mystery of long COVID. Available from URL: https://www.abc.net.au/7.30/up-to-a-third-of-people-take-longer-to-recover/13254214, 2021.</Citation></Reference><Reference><Citation>Farhadian S.F., Seilhean D., Spudich S. Neuropathogenesis of acute coronavirus disease 2019. Curr. Opin. Neurol. 2021;34:417&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pubmed">33852526</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2021;24:168&#x2013;175.</Citation><ArticleIdList><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Muccioli L., Pensato U., Cani I., Guarino M., Cortelli P., Bisulli F. COVID-19-associated encephalopathy and cytokine-mediated neuroinflammation. Ann. Neurol. 2020;88:860&#x2013;861.</Citation><ArticleIdList><ArticleId IdType="pubmed">32715524</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A., et al. Post-acute COVID-19 syndrome. Nat. Med. 2021;27:601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo B., Lapp S.A., Siegel B., et al. Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19. Mult. Scler. Relat. Disord. 2021;55</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8310416</ArticleId><ArticleId IdType="pubmed">34333272</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan R.K., Kashour T., Hamid Q., Halwani R., Tleyjeh I.M. Unraveling the mystery surrounding post-acute sequelae of COVID-19. Front. Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie K., Chan D., Watermeyer T. The cognitive consequences of the COVID-19 epidemic: collateral damage? Brain Commun. 2020;2:fcaa069.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314157</ArticleId><ArticleId IdType="pubmed">33074266</ArticleId></ArticleIdList></Reference><Reference><Citation>Ritchie M.E., Liu R., Carvalho B.S., Irizarry R.A. Comparing genotyping algorithms for illumina's infinium whole-genome SNP BeadChips. BMC Bioinform. 2011;12:68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3063825</ArticleId><ArticleId IdType="pubmed">21385424</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawcer S., Hellenthal G., Pirinen M., et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011;476:214&#x2013;219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3182531</ArticleId><ArticleId IdType="pubmed">21833088</ArticleId></ArticleIdList></Reference><Reference><Citation>Toniolo S., Di Lorenzo F., Scarioni M., Frederiksen K.S., Nobili F. Is the frontal lobe the primary target of SARS-CoV-2? J. Alzheimers Dis. 2021;81:75&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">33720900</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>